Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Quan Y et al. | 2023 | H9c2 cells (myoblast from embryonal rat myocard) | static magnetic field | - |
Iwasaki T et al. | 1978 | intact cell/cell culture, CHO (Chinese hamster ovary) cells, slime mold plasmodia (<i>Physarum polycepharum</i>), animal, frog embryos (<i>Xenopus laevis</i>) | static magnetic field, DC | 500 mT |
Valiron O et al. | 2005 | intact cell/cell culture, Rat2 (rat fibroblasts); NIH-3T3 (mouse fibroblasts); HeLa cells (human cervical carcinoma cell line); hippocampal embryonic murine neurons | static magnetic field, DC | 17 T |
Pacini S et al. | 2003 | intact cell/cell culture, Detroit 550 (human skin fibroblasts) | static magnetic field, DC | 200 mT |
Laszlo J et al. | 2010 | bacterium, <i>Bacillus circulans, Escherichia coli, Micrococcus luteus, Pseudomonas fluorescens, Salmonella enteritidis, Serratia marcescens, Staphylococcus aureus</i> and yeast (<i>Saccharomyces cerevisiae</i>) | static magnetic field, DC | 2.8–476.7 mT |
Martino CF et al. | 2010 | intact cell/cell culture, human vein endothelial cells (HUVEC) | static magnetic field, DC | 60–120 µT |
Lin CY et al. | 2013 | intact cell/cell culture, erythrocytes | static magnetic field, DC | 0.4–0.8 T |
Lin T et al. | 2014 | intact cell/cell culture, MDA-MB-468 cell line and T47D cell line (human breast carcinoma cells) | static magnetic field, DC | 3 mT |
Wang Z et al. | 2014 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and MCF-7 (human breast cancer cell line) | static magnetic field, DC | 0.26–0.33 T |
Zafari J et al. | 2015 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and fibroblasts | static magnetic field, DC | 5–30 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.